Blueprint Medicines Files 8-K on Shareholder Matters
| Field | Detail |
|---|---|
| Company | Blueprint Medicines Corp |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Blueprint Medicines filed an 8-K on June 18th for shareholder votes. Expect corporate updates soon.
AI Summary
Blueprint Medicines Corporation filed an 8-K on June 20, 2025, reporting on matters submitted to a vote of security holders as of June 18, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and principal executive offices located at 45 Sidney Street, Cambridge, Massachusetts.
Why It Matters
This filing indicates that Blueprint Medicines is engaging in corporate actions requiring shareholder approval, which could impact the company's governance and strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding shareholder matters and does not contain information about significant financial changes or operational risks.
Key Numbers
- 001-37359 — Commission File Number (Identifies the company's SEC filing history.)
- 26-3632015 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Blueprint Medicines Corporation (company) — Registrant
- June 18, 2025 (date) — Date of Earliest Event Reported
- June 20, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 45 Sidney Street, Cambridge, Massachusetts (address) — Principal executive offices
FAQ
What specific matters were submitted to a vote of security holders?
The filing states that the report is a 'CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934' and is titled 'Submission of Matters to a Vote of Security Holders'. However, the specific details of these matters are not provided in the excerpt.
When was the earliest event reported in this filing?
The earliest event reported was on June 18, 2025.
What is the principal executive office address for Blueprint Medicines Corporation?
The principal executive offices are located at 45 Sidney Street, Cambridge, Massachusetts, 02139.
In which state was Blueprint Medicines Corporation incorporated?
Blueprint Medicines Corporation was incorporated in Delaware.
What is the company's telephone number?
The company's telephone number, including area code, is (617) 374-7580.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Blueprint Medicines Corp.